Remdesivir may exacerbate ischemic acute kidney injury through molecular alterations in PGC-1α and apoptosis pathways: An in vivo study
PLOS One · 2026
DOI: 10.1371/journal.pone.0336221 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Yasin Bagheri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Apoptosis, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Acute Kidney Injury, Reperfusion Injury. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tabriz University of Medical Sciences.
Abstract (Originalsprache)
Acute kidney injury (AKI) represents a significant complication in patients with COVID-19. Although Remdesivir (RDV) has been shown to reduce viral loads and improve clinical outcomes, concerns persist regarding its safety in individuals with pre-existing kidney impairment. This study investigated the effects of RDV on a rat model of ischemia/reperfusion (I/R)-induced kidney damage. A total of 24 rats were divided randomly into four groups: (1) control, (2) I/R, (3) I/R + RDV by intraperitoneal (ip) injections, and (4) I/R + RDV by subcutaneous (sc) injection groups. Rats in groups 3 and 4 received a single dosage of RDV (25 mg/kg) one hour before I/R induction. The effect of RDV on master genes involved in the mitochondrial biogenesis [Peroxisome proliferator-activated receptor gamma coactivator (PGC-1α)] and dynamics [Dynamin-related protein 1 (Drp-1)], cellular stress [Activating transcription factor 3 (ATF3)], inflammation [Nuclear factor kappa B (NF-κB)], cell death [p53, p21 (a cyclin-dependent kinase inhibitor), and caspase-3], as well as oxidant malondialdehyde (MDA) and antioxidant factors were evaluated. Moreover, renal function, along with histology assessments were studied. Significant reductions in mitochondrial biogenesis marker PGC-1α ( P ≤ 0.04) and increases in caspase-3 ( P = 0.003) expression levels were observed in the I/R + RDV + sc group compared to the I/R group. Oxidative stress marker was elevated ( P = 0.016), while glutathione peroxidase (GPX) activity and total antioxidant capacity (TAC) were significantly decreased in the I/R + RDV + sc group (0.003 and 0.045, respectively). However, no significant changes were observed in p-p53, p-p21, NF-κB, or Drp-1 levels. Subcutaneous injection of RDV could induce more injury to the kidney compared to the intraperitoneal injection. These findings suggest that RDV may exacerbate AKI by hindering mitochondrial biogenesis and promoting renal cell apoptosis, without significantly affecting overall kidney function or histopathology. Clinically, these results highlight the need for caution when using RDV in patients with impaired renal function, especially during COVID-19 treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Pathobiology, Faculty of Veterinary Medicine, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
- Faculty of Veterinary Medicine, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
- Department of Clinical Science, Faculty of Veterinary Medicine, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
- Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Sepideh Zununi Vahed
Förderung
- Tabriz University of Medical Sciences
Zitieren
APA
Bagheri, Y., Malekinejad, Z., Hejazian, S. M., Abdollahpour, A., Khajepour, F., Farahbod, M., Ahmadi, S., Matin, S., & Zununi Vahed, S. (2026). Remdesivir may exacerbate ischemic acute kidney injury through molecular alterations in PGC-1α and apoptosis pathways: An in vivo study. PLOS One. https://doi.org/10.1371/journal.pone.0336221
Vancouver
Bagheri Y, Malekinejad Z, Hejazian SM, Abdollahpour A, Khajepour F, Farahbod M, et al. Remdesivir may exacerbate ischemic acute kidney injury through molecular alterations in PGC-1α and apoptosis pathways: An in vivo study. PLOS One. 2026. doi:10.1371/journal.pone.0336221
BibTeX
@article{Bagheri2026,
author = {Bagheri, Yasin and Malekinejad, Zahra and Hejazian, Seyyedeh Mina and Abdollahpour, Abdollah and Khajepour, Fatemeh and Farahbod, Mohaddeseh and Ahmadi, Sama and Matin, Samira and Zununi Vahed, Sepideh},
title = {Remdesivir may exacerbate ischemic acute kidney injury through molecular alterations in PGC-1α and apoptosis pathways: An in vivo study},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0336221}
}
EUVIMED